CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STW 01
The application of in vitro Toxicity Testing in 21 Century (TT21C) for next generation products 
(1) Imperial Brands PLC, Bristol, U.K.; (2) Reemtsma Cigarettenfabriken GmbH (an Imperial Brands PLC Company), Hamburg, Germany
The aim is to demonstrate the feasibility of TT21C in vitro methods as part of an overall assessment framework for next generation products (NGP). TT21C methodologies can be used to assess harm reduction potential of NGPs using human-derived...